Merck’s MilliporeSigma division supplies reagents, kits, and production technologies for global life science research and manufacturing.
New England Biolabs supplies enzymes, cloning kits, and reagents that accelerate molecular biology, genomics, and synthetic biology.
IDT delivers custom oligos, primers, CRISPR guides, and next-gen sequencing solutions to enable precise genetic research. Tailored for modern biology and life science teams.
Twist Bioscience provides silicon-based DNA synthesis, libraries, and antibody discovery solutions for pharma and biotech teams. Trusted by global research and diagnostic programs.
Precision NanoSystems builds microfluidic manufacturing technologies for lipid nanoparticles, mRNA, and gene therapy delivery. Tailored for modern biology and life science teams.
Synthego provides CRISPR genome engineering tools, kits, and engineered cells to accelerate gene editing research. Tailored for modern biology and life science teams.
Mammoth Biosciences builds CRISPR-based diagnostics and genome-editing tools leveraging novel Cas proteins. Tailored for modern biology and life science teams.
CRISPR Therapeutics is a clinical-stage gene editing company developing transformative therapies for serious diseases. Trusted by global research and diagnostic programs.
Intellia Therapeutics advances in vivo and ex vivo CRISPR/Cas9 genome editing therapies for genetic diseases. Tailored for modern biology and life science teams.
Editas Medicine is developing CRISPR genome editing medicines for ocular, hematologic, and oncologic diseases. Tailored for modern biology and life science teams.
bluebird bio develops gene therapies using lentiviral vectors to treat severe genetic diseases like thalassemia and sickle cell. Tailored for modern biology and life science teams.
Harvard’s Wyss Institute engineers biologically inspired technologies spanning organ-on-chip, robotics, and regenerative medicine. Tailored for modern biology and life science teams.
